From suboptimal outreach to member trust barriers, new market research shows health plans’ greatest challenges

From suboptimal outreach to member trust barriers, new market research shows health plans’ greatest challenges

The FDA’s approval of a nasal mist flu vaccine for at-home use represents more than just a convenient alternative to the traditional flu shot — it marks a significant shift in healthcare delivery, moving toward a decentralized model where patients can self-administer care from the comfort of their own homes.  

5 plans of attack: How payers can succeed facing new CMS rules in 2025 – and beyond

5 plans of attack: How payers can succeed facing new CMS rules in 2025 – and beyond

The FDA’s approval of a nasal mist flu vaccine for at-home use represents more than just a convenient alternative to the traditional flu shot — it marks a significant shift in healthcare delivery, moving toward a decentralized model where patients can self-administer care from the comfort of their own homes.